DANIEL GRIFFITH ANDERSON - Director at Sigilon Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
SGTX
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by DANIEL GRIFFITH ANDERSON since 07 Jan 2025

Holdings reported by DANIEL GRIFFITH ANDERSON for Sigilon Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2,022,222 $30,171,552 $14.92 02 Jun 2021 Direct

Transactions reported by DANIEL GRIFFITH ANDERSON for Sigilon Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.